课题基金 / 基金详情

Molecular mechanism of estrogen action to inhibit obesity

Molecular mechanism of estrogen action to inhibit obesity
雌激素抑制肥胖的分子机制
批准号:
08671890
负责人:
KURACHI Hirohisa
金额:
$1.41万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1997

项目摘要

项目成果

KURACHI Hirohisa的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Estrogen is known to regulate adipogenesis in rodents. Estrogen administration in ovariectomized rodents reduces lipoprotein lipase (LPL) gene expression in fat tissues. In this study we studied the mechanisms of transcriptional regulation of the murine LPL gene by estrogen. The 5'-flanking region of LPL gene (-1980 bp) was fused to CAT reporter gene, introduced into COS-1 cells with estrogen receptor expression vector and CAT activities were determined in the presence or the absence of estradiol. Estradiol at 10^<-6> M suppressed pLPL- (-1980) -CAT activity by 20-fold in COS-1 cells. We next determined the estrogen-suppressive element on the LPL promoter by systematically deleting the 5'-flanking region. The most potent region for the estrogen-dependent suppression was located between -1980 and -1570 bp. We narrowed down the region using 50 - 410 bp fragments between -1980 and -1570 bp fused to the minimal promoter-CAT gene. We found that the 50-bp- (-1620/-1570) element was important for estrogen-dependent suppression in LPL gene transcription. When this 50-bp element was deleted from the pLPL (-1980) -CAT construct, estrogen-dependent suppressiveness was decreased to 5-fold. Nuclear proteins from COS-1 cells specifically bound to this 50-bp element were observed by the electrophoretic mobility shift assay. These results collectively suggest that the 50-bp (-1620/-1570) element, which harbors no conventional estrogen-responsive element, may contain a novel cis-acting element which is crucial for estrogen-dependent suppression of the murine LPL gene transcription.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Establishment and functional analysis of induced pluripotent cancer cells in ovarian cancer
  • 批准号:
    24659723
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
  • 资助金额:
    $2.25万
  • 财政年份:
    2012
  • 负责人:
    KURACHI Hirohisa
  • 依托单位:
Study for the development of molecular therapy targeting the signal transduction pathway through epidermal growth factor receptor
  • 批准号:
    17390445
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $10.72万
  • 财政年份:
    2005
  • 负责人:
    KURACHI Hirohisa
  • 依托单位:
Antiatherogenic action of estrogen through inhibition of pathological proliferation in vascular smooth muscle sells
  • 批准号:
    14370523
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $8.45万
  • 财政年份:
    2002
  • 负责人:
    KURACHI Hirohisa
  • 依托单位:
Differentiation- dependent regulation of adhesion molecules in trophoblast cells
国内基金
海外基金
GREB1突变介导雌激素受体信号通路导致深部浸润型子宫内膜异位症的分子遗传机制研究
  • 批准号:
    82371652
  • 项目类别:
    面上项目
  • 资助金额:
    45.00万元
  • 批准年份:
    2023
  • 负责人:
    刘开江
  • 依托单位:
Estrogen/NDRG2/Na+/K+-ATPase调控通路在唾液生成和雌激素缺乏诱发口干症中的作用研究
新型雌激素受体GPR30在乳腺癌中的作用及机制探讨
  • 批准号:
    30872520
  • 项目类别:
    面上项目
  • 资助金额:
    28.0万元
  • 批准年份:
    2008
  • 负责人:
    涂刚
  • 依托单位:
雌激素调控子宫内膜异位症病灶神经产生致疼痛的机理研究
  • 批准号:
    30872754
  • 项目类别:
    面上项目
  • 资助金额:
    8.0万元
  • 批准年份:
    2008
  • 负责人:
    张信美
  • 依托单位: